By Josh Beckerman
Bristol-Myers Squibb Co. said Giovanni Caforio will succeed
Lamberto Andreotti as chief executive in May.
Mr. Andreotti, 64, will become executive chairman in May and
will remain chairman after his retirement in August.
Mr. Caforio, 50, joined the company in 2000 and was named chief
operating officer last year.
The drug company's current chairman, James M. Cornelius, 71, has
chosen not to stand for re-election to the board, the company
said.
Write to Josh Beckerman at josh.beckerman@wsj.com
Access Investor Kit for Bristol-Myers Squibb Co.
Visit
http://www.companyspotlight.com/partner?cp_code=P479&isin=US1101221083
Subscribe to WSJ: http://online.wsj.com?mod=djnwires